Turkish President Erdogan: We will, as planned, and with God's blessing, officially commission the domestically produced Kaan fighter jet into the Air Force.

Stock market fund flow chart: Today, the net outflow of main funds in the Shanghai and Shenzhen stock markets was 89.647 billion yuan, accounting for 4.68%; the net outflow of large-order funds was 32.024 billion yuan, accounting for 1.67%; and the net inflow of small-order funds was 65.967 billion yuan, accounting for 3.44%.

Individual Stock News: 1. Pony.ai (02026.HK) announced on the Hong Kong Stock Exchange that the final offer price for its international offering and Hong Kong public offering has been set at HK$139.00 per share. 2. Chow Tai Fook (01929.HK): Will make reasonable adjustments to its business and product retail prices based on the impact of policies, with the price increase commensurate with the increased costs brought about by the new policies. 3. China Mobile (00941.HK): China Mobile Group plans to transfer 0.19% of the company's shares to China National Petroleum Corporation. 4. Sa Sa International (00178.HK): Expects interim net profit to increase by 50%-56% year-on-year. 5. Weigao Group (01066.HK): Third-quarter revenue was approximately RMB 3.26 billion, an increase of approximately 2.6% year-on-year. 6. Shenzhen Holdings (00604.HK): Total contracted sales for the first three quarters were approximately RMB 9.838 billion, an increase of 24% year-on-year. 7. Hengrui Medicine (01276.HK): HRS-5965 capsules are proposed for inclusion in the priority review process; Revelumid tablets have been approved to conduct clinical trials. 8. China Supply Chain Industry (03708.HK): Signed a memorandum of understanding with Dimensional Technology to develop a new generation data center in Hong Kong using Kodon technology. 9. Zhaojin Mining (01818.HK): Entered into a strategic cooperation memorandum with Ant Financial to establish strategic partnerships in multiple fields based on the application of core technologies such as blockchain and artificial intelligence. 10. Touyun Bio (01332.HK) responded to abnormal stock price fluctuations: its wholly-owned subsidiary signed a RMB 1 billion framework agreement for the purchase of Chlamydomonas reinhardtii; other than this, it is unaware of any other reasons for the changes in price and trading volume.